申请人:Fujisawa Pharmaceutical Co., Ltd.
公开号:US05210092A1
公开(公告)日:1993-05-11
The invention concerns compounds of the formula ##STR1## represents a condensed or uncondensed imidazolyl ring and the rest of the variables are defined in the specification. They are angiotensin II antagonists useful for treating hypertension, etc.
该发明涉及公式为##STR1##的化合物,其中R1和R2分别表示紧缩或未紧缩的咪唑基环,其余变量在规范中定义。它们是血管紧张素II拮抗剂,可用于治疗高血压等疾病。